恒瑞医药(01276.HK)今日成功在港交所主板上市，今日开盘涨36.32%，报60.05港元/股，市值3965.41亿港元。5月15日，恒瑞医药宣布正式启动H股全球公开发售，计划发行224,519,800股H股（假设超额配售权及发售量调整权未行使），其中香港公开发售占5.5%（12,348,600股），国际配售94.5%（212,171,200股），发行价区间定为每股41.45—44.05港元。...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.